Supply Chain

As the pressure to reduce supply chain costs escalates, leaders are seeking more price transparency to help inform decisions, especially in relation to big-ticket items like procedural packs.

On its third-quarter earnings call Oct. 30, Pfizer said it is still experiencing manufacturing problems at some Hospira plants, meaning the supply shortage of several common sterile injectable drugs will continue for hospitals, according to Bloomberg.

Specialty pharmaceutical growth poses unique challenges for hospital pharmacies. Effectively managing these high-cost therapies that often have unpredictable demand requires a different inventory management strategy than traditional pharmaceuticals. Therefore, many health systems are turning to a consignment model, to better…

Here are five drugs or medical devices that have been approved by the FDA since Oct. 19: 

Amazon, through a partnership with health brand consultancy Arcadia Group, will sell an exclusive new brand of consumer-focused medical devices, including blood pressure cuffs and glucose monitors, according to CNBC.

The FDA approved  Genentech's drug Xofluza as the first new treatment for flu in about 20 years, the agency announced Oct. 24.

In an industry where health systems are facing increasing pressure to do more with less, doctors and nurses are working longer hours with more responsibilities. Meanwhile, hospitals want to reduce costs without sacrificing quality of care. Therefore it’s more important…

Northfield, Ill.-based Medline recently announced two new partnership agreements with Applied Silver and Premier.

Express Scripts Holding, a pharmacy benefit manager and specialty pharmacy that negotiates drug prices for 85 million people, plans to expand its full network offerings to "pharmacies predominantly engaged in mail-order practice," according to a notification sent to pharmacies.

Here are five drugs or medical devices that have been approved by the FDA since Oct. 12: